Intramuscular cell transplantation as a potential treatment of myopathies: Clinical and preclinical relevant data

Expert Opinion on Biological Therapy

Volumn 11, Issue 3, 2011, Pages 359-374

  Skuk, Daniel ^a   Tremblay, Jacques P ^b  

^a Université Laval   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

cell transplantation; clinical trials; myopathies; non human primates; skeletal muscle

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; DYSTROPHIN; TRANSCRIPTION FACTOR PAX7;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL TRANSPLANTATION; CONFOCAL MICROSCOPY; DUCHENNE MUSCULAR DYSTROPHY; GENETIC COMPLEMENTATION; HUMAN; MYOBLAST; MYOPATHY; NONHUMAN; REVIEW; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; SURVIVAL TIME;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; HUMANS; INJECTIONS, INTRAMUSCULAR; MUSCLE DEVELOPMENT; MUSCULAR DISEASES; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; MAMMALIA; MUS; PRIMATES;

EID: 79851480413     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2011.548800     Document Type: Review

References (100)

1. Lewis MR Rhythmical contraction of the skeletal muscle tissue observed in tissue cultures. Am J Physiol 1915;38:153-61
2. Partridge TA, Grounds M, Sloper JC. Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 1978;273:306-8 (Pubitemid 8332886)
3. Skuk D. Myoblast transplantation for inherited myopathies: a clinical approach. Expert Opin Biol Ther 2004;4:1871-85 (Pubitemid 39627139)
4. Collins CA, Olsen I, Zammit PS, et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005;122:289-301 (Pubitemid 41032991)
5. Betz EH, Firket H, Reznik M. Some aspects of muscle regeneration. Int Rev Cytol 1966;19:203-27
6. Zammit PS, Heslop L, Hudon V, et al. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp Cell Res 2002;281:39-49 (Pubitemid 35373781)
7. Peault B, Rudnicki M, Torrente Y, et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 2007;15:867-77 (Pubitemid 46621645)
8. Vauchez K, Marolleau JP, Schmid M, et al. Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities. Mol Ther 2009;17:1948-58
9. Yablonka-Reuveni Z, Nameroff M. Temporal differences in desmin expression between myoblasts from embryonic and adult chicken skeletal muscle. Differentiation 1990;45:21-8 (Pubitemid 20346650)
10. Wang J, Conboy I. Embryonic vs. adult myogenesis: challenging the 'regeneration recapitulates development' paradigm. J Mol Cell Biol 2010;2:1-4
11. Lepper C, Conway SJ, Fan CM. Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Nature 2009;460:627-31
12. Cossu G, Molinaro M. Cell heterogeneity in the myogenic lineage. Curr Top Dev Biol 1987;23:185-208
13. Konigsberg IR The differentiation of cross-striated myofibrils in short term cell culture. Exp Cell Res 1960;21:414-20
14. Vilquin JT, Marolleau JP, Hagege A, et al. Cell transplantation for post-ischemic heart failure. Arch Mal Coeur Vaiss 2002;95:1219-25 (Pubitemid 36091021)
15. Lipton BH, Schultz E. Developmental fate of skeletal muscle satellite cells. Science 1979;205:1292-4 (Pubitemid 10239861)
16. Watt DJ, Lambert K, Morgan JE, et al. Incorporation of donor muscle precursor cells into an area of muscle regeneration in the host mouse. J Neurol Sci 1982;57:319-31 (Pubitemid 13212268)
17. Kikuchi T, Doerr L, Ashmore CR. A possible mechanism of phenotypic expression of normal and dystrophic genomes on succinic dehydrogenase activity and fiber size within a single myofiber of muscle transplants. J Neurol Sci 1980;45:273-86 (Pubitemid 10133725)
18. Yao SN, Kurachi K. Implanted myoblasts not only fuse with myofibers but also survive as muscle precursor cells. J Cell Sci 1993;105:957-63 (Pubitemid 23258658)
19. Partridge TA, Morgan JE, Coulton GR, et al. Conversion of mdx myofibres from dystrophin-negative to-positive by injection of normal myoblasts. Nature 1989;337:176-9 (Pubitemid 19025378)
20. Karpati G, Pouliot Y, Zubrzycka-Gaarn E, et al. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol 1989;135:27-32 (Pubitemid 19228988)
21. Kinoshita I, Vilquin JT, Guerette B, et al. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994;17:1407-15 (Pubitemid 24362813)
22. Vilquin JT, Kinoshita I, Roy B, et al. Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation. J Cell Biol 1996;133:185-97 (Pubitemid 26107106)
23. Leriche-Guerin K, Anderson LV, Wrogemann K, et al. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice. Neuromuscul Disord 2002;12:167-73 (Pubitemid 33152735)
24. Mendell JR, Kissel JT, Amato AA, et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 1995;333:832-8
25. Skuk D, Goulet M, Roy B, et al. Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 2006;65:371-86 (Pubitemid 44264834)
26. Skuk D, Goulet M, Roy B, et al. First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up. Neuromuscul Disord 2007;17:38-46 (Pubitemid 46188617)
27. Skuk D, Roy B, Goulet M, et al. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther 2004;9:475-82 (Pubitemid 38404538)
28. Pavlath GK, Rich K, Webster SG, Blau HM. Localization of muscle gene products in nuclear domains. Nature 1989;337:570-3 (Pubitemid 19045544)
29. Ralston E, Hall ZW. Restricted distribution of mRNA produced from a single nucleus in hybrid myotubes. J Cell Biol 1992;119:1063-8
30. Hall ZW, Ralston E. Nuclear domains in muscle cells. Cell 1989;59:771-2 (Pubitemid 20022367)
31. Chretien F, Dreyfus PA, Christov C, et al. In vivo fusion of circulating fluorescent cells with dystrophin-deficient myofibers results in extensive sarcoplasmic fluorescence expression but limited dystrophin sarcolemmal expression. Am J Pathol 2005;166:1741-8 (Pubitemid 40734397)
32. Gussoni E, Blau HM, Kunkel LM. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 1997;3:970-7
33. Alameddine HS, Louboutin JP, Dehaupas M, et al. Functional recovery induced by satellite cell grafts in irreversibly injured muscles. Cell Transplant 1994;3:3-14 (Pubitemid 24055297)
34. Wernig A, Zweyer M, Irintchev A. Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles. J Physiol (Lond) 2000;522:333-45 (Pubitemid 30068510)
35. Wernig A, Irintchev A, Lange G. Functional effects of myoblast implantation into histoincompatible mice with or without immunosuppression. J Physiol (Lond) 1995;484:493-504
36. Irintchev A, Langer M, Zweyer M, et al. Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts. J Physiol (Lond) 1997;500:775-85 (Pubitemid 27207834)
37. Vracko R, Benditt EP. Basal lamina: the scaffold for orderly cell replacement. Observations on regeneration of injured skeletal muscle fibers and capillaries. J Cell Biol 1972;55:406-19
38. Kinoshita I, Vilquin JT, Tremblay JP. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice. Acta Neuropathol 1996;91:489-93 (Pubitemid 26133660)
39. Irintchev A, Rosenblatt JD, Cullen MJ, et al. Ectopic skeletal muscles derived from myoblasts implanted under the skin. J Cell Sci 1998;111:3287-97 (Pubitemid 28563032)
40. Satoh A, Labrecque C, Tremblay JP. Myotubes can be formed within implanted adipose tissue. Transplant Proc 1992;24:3017-19 (Pubitemid 23011810)
41. Pisani DF, Dechesne CA, Sacconi S, et al. Isolation of a highly myogenic CD34-negative subset of human skeletal muscle cells free of adipogenic potential. Stem Cells 2010;28:753-64
42. Borisov AB. Regeneration of skeletal and cardiac muscle in mammals: do nonprimate models resemble human pathology? Wound Repair Regen 1999;7:26-35 (Pubitemid 29159038)
43. Yokota T, Lu QL, Morgan JE, et al. Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J Cell Sci 2006;119:2679-87 (Pubitemid 44184004)
44. Gross JG, Morgan JE. Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury. Muscle Nerve 1999;22:174-85 (Pubitemid 29070391)
45. Xu X, Yang Z, Liu Q, Wang Y. In vivo fluorescence imaging of muscle cell regeneration by transplanted EGFP-labeled myoblasts. Mol Ther 2010;18:835-42
46. Heslop L, Beauchamp JR, Tajbakhsh S, et al. Transplanted primary neonatal myoblasts can give rise to functional satellite cells as identified using the Myf5nlacZl+ mouse. Gene Ther 2001;8:778-83 (Pubitemid 32509791)
47. Skuk D, Paradis M, Goulet M, et al. Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells. Mol Ther 2010;18:1689-97
48. Brimah K, Ehrhardt J, Mouly V, et al. Human muscle precursor cell regeneration in the mouse host is enhanced by growth factors. Hum Gene Ther 2004;15:1109-24 (Pubitemid 39552292)
49. Ehrhardt J, Brimah K, Adkin C, et al. Human muscle precursor cells give rise to functional satellite cells in vivo. Neuromuscul Disord 2007;17:631-8 (Pubitemid 47030920)
50. Negroni E, Riederer I, Chaouch S, et al. In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study. Mol Ther 2010;17:1771-8
51. Sampaolesi M, Blot S, D'Antona G, et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006;444:574-9 (Pubitemid 44864430)
52. Sampaolesi M, Torrente Y, Innocenzi A, et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003;301:487-92 (Pubitemid 36900300)
53. Torrente Y, Belicchi M, Sampaolesi M, et al. Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 2004;114:182-95 (Pubitemid 39071623)
54. Meng J, Muntoni F, Morgan JE. Stem cells to treat muscular dystrophies-Where are we? Neuromuscul Disord; doi:10.1016/j.nmd.2010.10.004
55. Skuk D, Goulet M, Roy B, Tremblay JP. Myoblast transplantation in whole muscle of nonhuman primates. J Neuropathol Exp Neurol 2000;59:197-206 (Pubitemid 30143878)
56. Skuk D, Goulet M, Roy B, Tremblay JP. Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans. Exp Neurol 2002;175:112-26 (Pubitemid 34507914)
57. Quenneville SP, Chapdelaine P, Skuk D, et al. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Mol Ther 2007;15:431-8 (Pubitemid 46111895)
58. El Fahime E, Mills P, Lafreniere JF, et al. The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation. Exp Cell Res 2002;280:169-78 (Pubitemid 35333759)
59. LafreniereJF, Mills P, BouchentoufM, Tremblay JP. Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp Cell Res 2006;312:1127-41
60. Mills P, Dominique JC, Lafreniere JF, et al. A synthetic mechano growth factor E Peptide enhances myogenic precursor cell transplantation success. Am J Transplant 2007;7:2247-59 (Pubitemid 47347850)
61. Mills P, Lafreniere JF, Benabdallah BF, et al. A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor. Exp Cell Res 2007;313:527-37 (Pubitemid 46186304)
62. Lafreniere JF, Caron MC, Skuk D, et al. Growth factor coinjection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success. Cell Transplant 2009;18:719-30
63. Skuk D, Goulet M, Paradis M, Tremblay JP. Intramuscular migration capacity of transplanted myoblasts after subcutaneous implantation: a study in nonhuman primates. Tissue Eng 2009;15:713
64. Vilquin JT, Asselin I, Guerette B, et al. Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation 1995;59:422-6
65. Pin CL, Merrifield PA. Developmental potential of rat L6 myoblasts in vivo following injection into regenerating muscles. Dev Biol 1997;188:147-66 (Pubitemid 27360094)
66. Cantini M, Massimino ML, Catani C, et al. Gene transfer into satellite cell from regenerating muscle: bupivacaine allows beta-Gal transfection and expression in vitro and in vivo. In Vitro Cell Dev Biol Anim 1994;30A:131-3 (Pubitemid 24164793)
67. Lazerges C, Daussin PA, Coulet B, et al. Transplantation of primary satellite cells improves properties of reinnervated skeletal muscles. Muscle Nerve 2004;29:218-26 (Pubitemid 38166843)
68. Bouchentouf M, Benabdallah BF, Bigey P, et al. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther 2008;15:404-14 (Pubitemid 351330998)
69. Skuk D, Roy B, Goulet M, Tremblay JP. Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle. Exp Neurol 1999;155:22-30 (Pubitemid 29072601)
70. Kinoshita I, Vilquin JT, Asselin I, et al. Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin produced only a relatively small increase of dystrophin-positive membrane. Muscle Nerve 1998;21:91-103 (Pubitemid 28041685)
71. Skuk D, Goulet M, Tremblay JP. Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplant 2006;15:659-63 (Pubitemid 44904677)
72. Cesar M, Roussanne-Domergue S, Coulet B, et al. Transplantation of adult myoblasts or adipose tissue precursor cells by high-density injection failed to improve reinnervated skeletal muscles. Muscle Nerve 2008;37:219-30 (Pubitemid 351214169)
73. Richard PL, Gosselin C, Laliberte T, et al. A first semimanual device for clinical intramuscular repetitive cell injections. Cell Transplant 2010;19:67-78
74. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. Quantitative studies of efficacy of myoblast transplantation. Muscle Nerve 1994;(suppl 1):S261
75. Huard J, Acsadi G, Jani A, et al. Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther 1994;5:949-58 (Pubitemid 24304756)
76. Guerette B, Skuk D, Celestin F, et al. Prevention by anti-LFA-1 ofacute myoblast death following transplantation. J Immunol 1997;159:2522-31 (Pubitemid 127681048)
77. Qu Z, Balkir L, Van Deutekom JC, et al. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998;142:1257-67 (Pubitemid 28429107)
78. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 1999;144:1113-22
79. Skuk D, Caron NJ, Goulet M, et al. Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J Neuropathol Exp Neurol 2003;62:951-67 (Pubitemid 37159035)
80. Holzer N, Hogendoorn S, Zurcher L, et al. Autologous transplantation of porcine myogenic precursor cells in skeletal muscle. Neuromuscul Disord 2005;15:237-44 (Pubitemid 40255779)
81. Guerette B, Asselin I, Skuk D, et al. Control of inflammatory damage by anti-LFA-1: increase success ofmyoblast transplantation. Cell Transplant 1997;6:101-7 (Pubitemid 27188292)
82. Sammels LM, Bosio E, Fragall CT, et al. Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy. Transplantation 2004;77:1790-7 (Pubitemid 38822198)
83. Bouchentouf M, Benabdallah BF, Rousseau J, et al. Induction of Anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways. Am J Transplant 2007;7:1491-505 (Pubitemid 46776268)
84. Cousins JC, Woodward KJ, Gross JG, et al. Regeneration of skeletal muscle from transplanted immortalised myoblasts is oligoclonal. J Cell Sci 2004;117:3259-69 (Pubitemid 39139911)
85. Skuk D, Paradis M, Goulet M, Tremblay JP. Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies. Transplantation 2007;84:1307-15 (Pubitemid 351339319)
86. Jones PH. Implantation of cultured regenerate muscle cells into adult rat muscle. Exp Neurol 1979;66:602-10 (Pubitemid 10135307)
87. Guerette B, Asselin I, Vilquin JT, et al. Lymphocyte infiltration following allo-and xenomyoblast transplantation in mdx mice. Muscle Nerve 1995;18:39-51
88. Irintchev A, Zweyer M, Wernig A. Cellular and molecular reactions in mouse muscles after myoblast implantation. J Neurocytol 1995;24:319-31
89. Wernig A, Irintchev A. "Bystander" damage of host muscle caused by implantation of MHC-compatible myogenic cells. J Neurol Sci 1995;130:190-6
90. Kinoshita I, Roy R, Dugre FJ, et al. Myoblast transplantation in monkeys: control of immune response by FK506. J Neuropathol Exp Neurol 1996;55:687-97 (Pubitemid 26187395)
91. Kinoshita I, Vilquin JT, Gravel C, et al. Myoblast allotransplantation in primates. Muscle Nerve 1995;18:1217-18
92. Pavlath GK, Rando TA, Blau HM. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J Cell Biol 1994;127:1923-32
93. Camirand G, Rousseau J, Ducharme ME, et al. Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism. Am J Transplant 2004;4:1255-65 (Pubitemid 39013571)
94. Stephan L, Pichavant C, Bouchentouf M, et al. Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use. Cell Transplant 2006;15:835-46 (Pubitemid 46098862)
95. Camirand G, Caron NJ, Turgeon NA, et al. Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation. Transplantation 2002;73:453-61 (Pubitemid 34174297)
96. Camirand G, Stephan L, Rousseau J, et al. Central tolerance to myogenic cell transplants does not include muscle neoantigens. Transplantation 2008;85:1791-801
97. Ohtsuka Y, Udaka K, Yamashiro Y, et al. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy. J Immunol 1998;160:4635-40 (Pubitemid 28217325)
98. Brazelton TR, Morris RE. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide. Curr Opin Immunol 1996;8:710-20 (Pubitemid 26385402)
99. Gussoni E, Bennett RR, Muskiewicz KR, et al. Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest 2002;110:807-14
100. Dell'Agnola C, Wang Z, Storb R, et al. Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs. Blood 2004;104:4311-18 (Pubitemid 39620188)